GlaxoSmithKline (GSK) Consumer Healthcare has announced a further £18m investment in their manufacturing facility at Coleford, Gloucestershire. The investment is for a new high speed, high efficiency bottling plant which will manufacture a range of Lucozade and Ribena products using state of the art technology.
